Robert J. Gould, See Remarks at Fulcrum Therapeutics, Inc. (FULC), sold 6,866 shares at $20.17 ($138K) on 2020-06-05, disclosed to the SEC on 2020-06-09.
Open-market sale of $138k FULC by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.17 | 3,433 | $69K | 50.0% |
| 2 | $20.17 | 3,433 | $69K | 50.0% |
| Total | $20.17 avg | 6,866 | $138K | 100% |
| Filing → |
| FULC | SELL | 2026-01-06 | $356K | — | Filing → |
| FULC | SELL | 2025-11-21 | $165K | — | Filing → |
| FULC | SELL | 2023-01-13 | $101K | — | Filing → |